Forbes November 14, 2024
Erez Meltzer

Erez Meltzer, CEO & Board Member of Nanox, is a prominent Israel business leader with 35+ years experience leading various global companies.

The promise of personalized medicine is finally becoming a reality. Thanks to the advent of artificial intelligence (AI), we’re witnessing a transformation in patient care that goes beyond incremental improvements. AI is now reshaping how we approach diagnostics, treatment planning and ongoing patient management, offering the potential for truly individualized healthcare at scale.

While the concept of personalized medicine isn’t new, the ability to implement it effectively has been limited by the sheer complexity of human biology and the vast amount of data involved. This is where AI shines, offering the computing power and analytic capabilities to process...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Pharma / Biotech, Precision Medicine, Provider, Technology
AI agents’ momentum won’t stop in 2025
The cybersecurity provider’s next opportunity: Making AI safer
OpenAI launches ChatGPT desktop integrations, rivaling Copilot
Apple’s AI-Powered Smart Home Hub May Include eCommerce Capabilities
IPO Market Struggles as Investors Flock to AI

Share This Article